Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel Mackman

Showing results (251-260 of 397) with videos related to

Pageof 40
Sort By:
Blood|September 23, 2006
Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injuryJacob Sevastos, Sean E Kennedy, Darren R Davis, et al.
European Journal of Clinical Investigation|February 13, 2013
Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological featuresJohannes Thaler, Cihan Ay, Nigel Mackman, et al.
The Journal of Experimental Medicine|August 29, 2007
COX-2 suppresses tissue factor expression via endocannabinoid-directed PPARdelta activationMallika Ghosh, Haibin Wang, Youxi Ai, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 6, 2008
Contribution of host-derived tissue factor to tumor neovascularizationJoanne Yu, Linda May, Chloe Milsom, et al.
Journal of Thrombosis and Haemostasis : JTH|October 24, 2021
Genetic deletion of platelet PAR4 results in reduced thrombosis and impaired hemostatic plug stabilityRobert H Lee, Tomohiro Kawano, Steven P Grover, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Attenuation of Atherosclerosis with PAR4 Deficiency: Differential Platelet Outcomes in apoE <sup>-/-</sup> vs. Ldlr <sup>-/-</sup> MiceCaris A Wadding-Lee, Megan Jay, Shannon M Jones, et al.
Circulation Research|February 26, 2003
Chlamydia pneumoniae induces tissue factor expression in mouse macrophages via activation of Egr-1 and the MEK-ERK1/2 pathwayFlorian Bea, Mirja H Puolakkainen, Timothy McMillen, et al.
Research and Practice in Thrombosis and Haemostasis|February 4, 2021
Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortalityFien A von Meijenfeldt, Sebastian Havervall, Jelle Adelmeijer, et al.
Communications Biology|March 7, 2025
Extravascular coagulation regulates haemostasis independently of activated platelet surfaces in an in vivo mouse modelAsuka Sakata, Kohei Tatsumi, Naoki Matsumoto, et al.
The Journal of Biological Chemistry|February 19, 2008
Transcriptional regulation of EGR-1 by the interleukin-1-JNK-MKK7-c-Jun pathwayElke Hoffmann, Judith Ashouri, Sabine Wolter, et al.
Pageof 40

Showing results (251-260 of 397) with videos related to

Sort By:
Pageof 40
Blood|September 23, 2006
Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injuryJacob Sevastos, Sean E Kennedy, Darren R Davis, et al.
European Journal of Clinical Investigation|February 13, 2013
Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological featuresJohannes Thaler, Cihan Ay, Nigel Mackman, et al.
The Journal of Experimental Medicine|August 29, 2007
COX-2 suppresses tissue factor expression via endocannabinoid-directed PPARdelta activationMallika Ghosh, Haibin Wang, Youxi Ai, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 6, 2008
Contribution of host-derived tissue factor to tumor neovascularizationJoanne Yu, Linda May, Chloe Milsom, et al.
Journal of Thrombosis and Haemostasis : JTH|October 24, 2021
Genetic deletion of platelet PAR4 results in reduced thrombosis and impaired hemostatic plug stabilityRobert H Lee, Tomohiro Kawano, Steven P Grover, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Attenuation of Atherosclerosis with PAR4 Deficiency: Differential Platelet Outcomes in apoE <sup>-/-</sup> vs. Ldlr <sup>-/-</sup> MiceCaris A Wadding-Lee, Megan Jay, Shannon M Jones, et al.
Circulation Research|February 26, 2003
Chlamydia pneumoniae induces tissue factor expression in mouse macrophages via activation of Egr-1 and the MEK-ERK1/2 pathwayFlorian Bea, Mirja H Puolakkainen, Timothy McMillen, et al.
Research and Practice in Thrombosis and Haemostasis|February 4, 2021
Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortalityFien A von Meijenfeldt, Sebastian Havervall, Jelle Adelmeijer, et al.
Communications Biology|March 7, 2025
Extravascular coagulation regulates haemostasis independently of activated platelet surfaces in an in vivo mouse modelAsuka Sakata, Kohei Tatsumi, Naoki Matsumoto, et al.
The Journal of Biological Chemistry|February 19, 2008
Transcriptional regulation of EGR-1 by the interleukin-1-JNK-MKK7-c-Jun pathwayElke Hoffmann, Judith Ashouri, Sabine Wolter, et al.
Pageof 40